Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effectiveness and Safety of Ivermectin as add-on Therapy in Severe COVID-19 Management

NCT04646109 is registered in ClinicalTrials.gov with Afyonkarahisar Health Sciences University as lead sponsor.

NCT NCT04646109
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04646109 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effectiveness and Safety of Ivermectin as add-on Therapy in Severe COVID-19 Management
Lead sponsor
Afyonkarahisar Health Sciences University
Phase
Phase 3
Overall status
Completed
Start date
May 11, 2020
Completion date
September 2, 2020
Enrollment
66 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19